Showing results (41-50 of 324) with videos related to
Sort By:
Pageof 33
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.Melanoma Research|April 9, 2010
GPNMB expression in uveal melanoma: a potential for targeted therapyMichelle D Williams, Bita Esmaeli, Aydin Soheili, et al.Cancer Medicine|October 21, 2020
An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancerDeng Pan, Yubo Tang, Jiao Tong, et al.Journal for Immunotherapy of Cancer|June 23, 2025
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug developmentLeisha A Emens, Christine Moussion, Patrick Hwu, et al.Cancer Research|November 25, 2010
Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cellsNatalia Martin-Orozco, Yufeng Li, Yijun Wang, et al.Journal of Hematology & Oncology|April 6, 2012
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progressionDavid Z Chang, Ying Ma, Baoan Ji, et al.Blood|September 1, 2012
Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40Yan Yang, Chengwen Liu, Weiyi Peng, et al.Cancer Immunology Research|February 23, 2017
Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone AcetyltransferasesJiemiao Hu, Chantale Bernatchez, Liangfang Zhang, et al.Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.Cancers|February 1, 2019
Adjuvant Ipilimumab in High-Risk Uveal MelanomaEric Fountain, Roland L Bassett, Suzanne Cain, et al.Pageof 33